Clinical trial
Hybrid Method Between Low-ratio Premixed Insulin and Short Acting Insulin in Fasting Type 2 Diabetic Patients in Ramadan: Safety and Efficacy
NCT06528002 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hybrid Method Between Low-ratio Premixed Insulin and Short Acting Insulin in Fasting Type 2 Diabetic Patients in Ramadan: Safety and Efficacy
- Lead sponsor
- Sohag University
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 1, 2024
- Completion date
- June 15, 2024
- Enrollment
- 45 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
calculation of body mass index, continous blood glucose monitoring, measurment of blood pressure